Defining the 90-day cost structure of lower extremity revascularization for alternative payment model assessment DISCUSSION

• Type of Material: Article
• Authors: Yazan Duwayri, Emory University; Francesco Aiello, University of Massachusetts; Margaret Tracci, University of Virginia; Susan Nedza, Northwestern University; Patrick C Ryan, Nashville Vascular and Vein Institute; John G Adams J, Columbia Surgical Associates; William P Shutze, Texas Vascular Associates; Ying Wei Lum, Johns Hopkins School of Medicine; Karen Woo, University of California, Los Angeles
• Language: English
• Date: 2021-02-01
• Publisher: MOSBY-ELSEVIER
• Publication Version: Author Accepted Manuscript (After Peer Review)
• Copyright Statement: © 2020 Published by Elsevier Inc. on behalf of the Society for Vascular Surgery.
• License: Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International
• Title of Journal or Parent Work: JOURNAL OF VASCULAR SURGERY
• Volume: 73
• Issue: 2
• Start Page: 672
• End Page: 673
• Grant/Funding Information: This work was funded in part by a Quality Block Grant given to the Society for Vascular Surgery by W. L. Gore to support quality initiatives. GORE had no involvement in the study design, or collection, analysis, or interpretation of the data, manuscript writing, or the decision to submit for publication.
• Keywords: Cardiovascular System & Cardiology; Surgery; Science & Technology; Life Sciences & Biomedicine; Peripheral Vascular Disease

Abstract

The U.S. healthcare system is undergoing a broad transformation from the traditional fee-for-service model to value-based payments. The changes introduced by the Medicare Quality Payment Program, including the establishment of Alternative Payment Models, ensure that the practice of vascular surgery is likely to face significant reimbursement changes as payments transition to favor these models. The Society for Vascular Surgery Alternative Payment Model taskforce was formed to explore the opportunities to develop a physician-focused payment model that will allow vascular surgeons to continue to deliver the complex care required for peripheral arterial disease (PAD).